Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 10-Dec-15 6:25 PM View:  | Steiner Eugen Director | Nephrogenex, Inc. (NRX) | 09-Dec-15 | Grant | 76,045 | -- | -- | 100% 0 to 76.05K | |
| 12-Nov-15 11:54 AM View: | Hamill John Chief Financial Officer | Nephrogenex, Inc. (NRX) | 10-Nov-15 | Grant | 136,381 | -- | -- | 100% 0 to 136.38K | |
| 12-Nov-15 11:56 AM View: | Legault Pierre Chief Executive Officer Director | Nephrogenex, Inc. (NRX) | 10-Nov-15 | Grant | 646,930 | -- | -- | 5175% 12.5K to 659.43K | |
| 12-Nov-15 11:52 AM View: | Patel Jaikrishna Chief Medical Officer | Nephrogenex, Inc. (NRX) | 10-Nov-15 | Grant | 97,306 | -- | -- | 100% 0 to 97.31K | |
| 06-Jan-15 5:55 PM View: | Rho Ventures V, L.P. 10% Owner | Nephrogenex, Inc. (NRX) | 06-Jan-15 | Market Sale | 20,941 | $9.90 | $207,339.00 | (< 1%) 3.39M to 3.37M | (3%) |
| 06-Jan-15 5:55 PM View: | Rho Ventures V, L.P. 10% Owner | Nephrogenex, Inc. (NRX) | 05-Jan-15 | Market Sale | 164,919 | $10.54 | $1,738,060.00 | (5%) 3.55M to 3.39M | 4% |
| 06-Jan-15 5:55 PM View: | Rho Ventures V, L.P. 10% Owner | Nephrogenex, Inc. (NRX) | 02-Jan-15 | Market Sale | 88,000 | $10.83 | $953,207.00 | (2%) 3.64M to 3.55M | 6% |
| 25-Nov-14 4:07 PM View: | Peterson Bob VP of Prod. Dev. & Reg. Aff's. | Nephrogenex, Inc. (NRX) | 25-Nov-14 | Market Purchase | 2,000 | $4.20 | $8,400.00 | 100% 0 to 2.0K | |
| 19-Feb-14 4:16 PM View: | Markham Richard J Director 10% Owner | Nephrogenex, Inc. (NRX) | 14-Feb-14 | Grant Duplicate | 412,592 | -- | -- | 5% 8.64M to 9.05M | |
| 19-Feb-14 4:43 PM View: | Rho Ventures V, L.P. Director 10% Owner | Nephrogenex, Inc. (NRX) | 14-Feb-14 | Grant Duplicate | 180,997 | -- | -- | 9% 2.09M to 2.27M | |
| 19-Feb-14 4:17 PM View: | Seltzer Robert R. Director 10% Owner | Nephrogenex, Inc. (NRX) | 14-Feb-14 | Conversion Duplicate | 3,038,500 | -- | -- | 34% 9.05M to 12.09M | |
| 19-Feb-14 4:03 PM View: | Care Capital III LLC Director 10% Owner | Nephrogenex, Inc. (NRX) | 14-Feb-14 | Purchase | 790,000 | $12.00 | $9,480,000.00 | 7% 12.09M to 12.88M | |
| 19-Feb-14 4:17 PM View: | Seltzer Robert R. Director 10% Owner | Nephrogenex, Inc. (NRX) | 14-Feb-14 | Grant Duplicate | 412,592 | -- | -- | 5% 8.64M to 9.05M | |
| 19-Feb-14 4:03 PM View: | Care Capital III LLC Director 10% Owner | Nephrogenex, Inc. (NRX) | 14-Feb-14 | Conversion | 3,038,500 | -- | -- | 34% 9.05M to 12.09M | |
| 19-Feb-14 4:18 PM View: | Vogelbaum Martin Director | Nephrogenex, Inc. (NRX) | 14-Feb-14 | Conversion | 1,145,830 | -- | -- | 50% 2.27M to 3.42M | |
| 19-Feb-14 4:16 PM View: | Markham Richard J Director 10% Owner | Nephrogenex, Inc. (NRX) | 14-Feb-14 | Purchase Duplicate | 790,000 | $12.00 | $9,480,000.00 | 7% 12.09M to 12.88M | |
| 19-Feb-14 4:03 PM View: | Care Capital III LLC Director 10% Owner | Nephrogenex, Inc. (NRX) | 14-Feb-14 | Grant | 412,592 | -- | -- | 5% 8.64M to 9.05M | |
| 19-Feb-14 4:18 PM View: | Vogelbaum Martin Director | Nephrogenex, Inc. (NRX) | 14-Feb-14 | Grant | 180,997 | -- | -- | 9% 2.09M to 2.27M | |
| 19-Feb-14 4:16 PM View: | Markham Richard J Director 10% Owner | Nephrogenex, Inc. (NRX) | 14-Feb-14 | Conversion Duplicate | 3,038,500 | -- | -- | 34% 9.05M to 12.09M | |
| 19-Feb-14 4:43 PM View: | Rho Ventures V, L.P. Director 10% Owner | Nephrogenex, Inc. (NRX) | 14-Feb-14 | Conversion Duplicate | 1,145,830 | -- | -- | 50% 2.27M to 3.42M | |
| 19-Feb-14 4:17 PM View: | Seltzer Robert R. Director 10% Owner | Nephrogenex, Inc. (NRX) | 14-Feb-14 | Purchase Duplicate | 790,000 | $12.00 | $9,480,000.00 | 7% 12.09M to 12.88M |
